For mutations that appear only in CFC but not in cancer we used the most prevalent CFC MEK mutation, MEK1-Y130C as well as its MEK2 equivalent Y134C43–48. This evidence concerns the gene MAP2K7 and cardiofaciocutaneous syndrome.